IP Library Granted Patent US 8,013,017
Granted Patent B2
US 8,013,017 · App. 12/479,524 · Granted Sep 6, 2011

Dermatological compositions and methods

Assignee: Upsher-Smith Laboratories, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,013,017
App. No.
12/479,524
Granted
Sep 6, 2011
Kind
B2
Abstract

Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.

Claims (30)

1. A dermatological composition comprising:

ammonium lactate in an amount of about 10% to about 15% by weight;

potassium lactate in an amount of about 3% to about 7% by weight; and

sodium lactate in an amount of about 3% to about 7% by weight;

wherein the composition has a pH of about 4.5 to about 5.5.

2. The dermatological composition of claim 1 further comprising at least one anti-foaming agent.

3. The dermatological composition of claim 1 further comprising at least one non-ionic surfactant selected from the group consisting of glyceryl stearate, PEG 100-stearate, polyoxyl-20-cetostearyl ether, glyceryl monooleate, glyceryl palmitosterate, self-emulsifying wax, polyoxyl-20-stearate, polyoxyl-40-stearate, polyoxyl-60-stearate, polyoxyl-80-stearate, polyoxyl-20-oleate, polyoxyl-40-oleate, polyoxyl-60-oleate, polyoxyl-80-oleate, polyoxyl-20-palmitate, polyoxyl-40-palmitate, polyoxyl-60-palmitate, polyoxyl-80-palmitate, emulsifying wax, laureth-2, laureth-4, laureth-6, laureth-8, and combinations thereof.

4. The dermatological composition of claim 1 further comprising at least one preservative selected from the group consisting of methyl paraben, ethyl paraben, propyl paraben, propyl paraben sodium salt, propyl paraben potassium salt, butyl paraben, and combinations thereof.

5. The dermatological composition of claim 4 wherein the preservative is present in the composition in an amount of about 0.02 wt.-% to about 1 wt.-%.

6. The dermatological composition of claim 1 further comprising at least one humectant selected from the group consisting of glycerin 99.5%, glycerin 95%, glycerin 85%, propylene glycol, butylene glycol, and combinations thereof.

7. The dermatological composition of claim 6 wherein the humectant is present in the composition in an amount of about 1 wt.-% to about 15 wt.-%.

8. The dermatological composition of claim 1 further comprising at least one anti-inflammatory agent.

9. The dermatological composition of claim 1 further comprising at least one anesthetic agent.

10. A dermatological composition comprising:

about 10 weight percent to about 15 weight percent of ammonium lactate;

about 3 weight percent to about 7 weight percent of sodium lactate;

about 3 weight percent to about 7 weight percent of potassium lactate;

about 1 weight percent to about 20 weight percent of light mineral oil;

about 2 weight percent to about 10 weight percent of emulsifying wax;

about 1 weight percent to about 5 weight percent of stearic acid;

about 0.01 weight percent to about 1 weight percent of propyl paraben;

about 1 weight percent to about 10 weight percent of glycerin;

about 0.0001 weight percent to about 10 weight percent of xanthan gum;

about 1 weight percent to about 15 weight percent of propylene glycol;

about 0.02 weight percent to about 1 weight percent of methyl paraben; and

about 30% and typically no greater than about 60% by weight of water;

wherein the composition has a pH of about 4.5 to about 5.5.

11. The dermatological composition of claim 1 which is odor-free.

12. The dermatological composition of claim 10 which is odor-free.

13. The dermatological composition of claim 10 further comprising an anesthetic, an anti-inflammatory agent, or a combination thereof.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: ADVANTICE HEALTH, LLC
Reel/Frame 059547/0972 →
SECURITY INTEREST Recorded Apr 1, 2022
From: ADVANTICE HEALTH, LLC
To: EVOLUTION CREDIT PARTNERS I, L.P.
Reel/Frame 059472/0893 →
SECURITY INTEREST Recorded Apr 1, 2022
From: ADVANTICE HEALTH, LLC
To: MIDCAP FINANCIAL TRUST
Reel/Frame 059469/0496 →
SECURITY INTEREST Recorded Dec 13, 2021
From: ADVANTICE HEALTH, LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 058374/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2021
From: JAZZ HOLDCO, INC.
To: ADVANTICE HEALTH, LLC
Reel/Frame 057980/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2021
From: SANDOZ INC.
To: JAZZ HOLDCO, INC.
Reel/Frame 057979/0940 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2017
From: JP MORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: UPSHER-SMITH LABORATORIES, INC.
Reel/Frame 042548/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2017
From: UPSHER-SMITH LABORATORIES, INC.
To: SANDOZ INC.
Reel/Frame 040968/0023 →
RELEASE OF SECURITY INTEREST Recorded Dec 15, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: UPSHER-SMITH LABORATORIES, INC.
Reel/Frame 040961/0710 →
SECURITY AGREEMENT Recorded Jun 13, 2012
From: UPSHER-SMITH LABORATORIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028371/0759 →
Continuity (4)
Continuation 10977374 · Oct 29, 2004
Division 10159562 · May 31, 2002
Provisional Application 60295105 · May 31, 2001
Related Publication 20090247632A1 · Oct 1, 2009